Corporate ManufacturerCached Profile

LA JOLLA PHARMACEUTICAL COMPANY

Manufacturer Corporate ID: 100000231830
Subsidiaries Logged: 1 entities
LIFETIME CORPORATE SPEND
$396,187
General Payments Aggregated (2021–2025)
Data coverage: 2021 – 2025  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Top Funded Physicians

Physicians receiving the highest promotional payments from this corporation.

1. Dr. ARA KLIJIANMedical Doctor
$30,678
2. Dr. JONATHAN CHOWMedical Doctor
$28,050
3. Dr. DAVID BOLDTMedical Doctor
$20,695
$17,055
5. Dr. BRUCE FRIEDMANMedical Doctor
$16,892

Top Promoted Products

Drugs or medical devices receiving the highest marketing backing.

1. GIAPREZA$250,976 (63.3%)
2. XERAVA$93,806 (23.7%)
3. XACDURO$26,686 (6.7%)
4. ZEVTERA$20,549 (5.2%)

Active Subsidiary Entities

Corporate subsidiaries and brands associated with this manufacturer ID in Open Payments.

LA JOLLA PHARMACEUTICAL COMPANY

Corporate General Payouts Log

Federal registry records of promotional speaking, consulting, meals, and offsets.

Year:
2025
2025
2024
2023
2022
2021

Querying Open Payments Database

Fetching live CMS.gov records for LA JOLLA PHARMACEUTICAL COMPANY...